Clinsys   Report issue

For profit Phase 2
Founded: Berkeley Heights NJ United States (1992)
Status: No NME R&D (1992)

Organization Overview

First Clinical Trial
2009
NCT00914186
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

ts022 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dermatitis (Phase 2)

Dermatitis, Atopic (Phase 2)

Eczema (Phase 2)

Pruritus (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1